Beam Therapeutics Inc.

Beam Therapeutics is a biotechnology company developing genetic medicines to treat serious inherited diseases. The company uses a technique called gene editing to fix faulty genes that cause conditions like sickle cell disease, alpha-1 antitrypsin deficiency, and phenylketonuria. One of their treatments uses a patient's own blood cells, edited to correct the genetic problem and then put back into the patient's body. The company also partners with larger pharmaceutical companies like Pfizer to research gene editing approaches for rare liver, muscle, and nervous system diseases.